Ajanta Pharma: The Exchange has received revised Disclosure
Ajanta Pharma (AJANTPHARM) filed a disclosure titled "The Exchange has received revised Disclosure". The company is valued at about ₹41,936 crore.
What happened
Ajanta Pharma (AJANTPHARM) filed a disclosure with the exchanges on 17 November 2026 at 10:18 AM titled "The Exchange has received revised Disclosure".
Company snapshot
Ajanta Pharma is a mid-cap company in the Healthcare sector, with a market value of about ₹41,936 crore.
The stock last traded at ₹3,356, against a 52-week range of ₹2,445.8–₹3,796 (11.6% below the high).
Before this filing the shares had moved −0.5% over the month and −10.6% over three months. Average daily turnover over the last 20 sessions was about ₹59.24 crore.
Promoters held 63.47% at the end of Q2 FY27; 20.65% of promoter shares were pledged. Foreign institutions owned 7.63% and domestic institutions 21.94%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 1,354 | 260.2 | 20.83 |
| Q3 FY26 | 1,375 | 273.8 | 21.91 |
| Q4 FY26 | 1,422 | 266.7 | 21.35 |
| Q1 FY27 | 1,626 | 330 | 26.75 |
| Q2 FY27 | 1,794 | 388.1 | 31.07 |
What history shows
This is not the company's first pledge disclosure: BCEIE has at least 12 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 0.6% on average the next trading day and was up 0.5% on average after five days (12 filings with price data).
Across 17 similar disclosures by other Healthcare companies, shares moved −1.9% on average the next day and −1.3% over five days; 24% of them rose the next day.
Market-wide, 626 pledge filings with an impact score of 50 or more saw an average next-day move of +0.7%, with 52% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 9 Nov 2026 | The Exchange has received Disclosure under Regulation 31(1) and… | −0.6% | — |
| 21 Oct 2026 | The Exchange has received Disclosure under Regulation 31(1) and… | −0.9% | +4.9% |
| 6 Oct 2026 | The Exchange has received Disclosure under Regulation 31(1) and… | +2.4% | −4.5% |
| 28 Sept 2026 | The Exchange has received Disclosure under Regulation 31(1) and… | +0.3% | — |
| 18 Sept 2026 | The Exchange has received Disclosure under Regulation 31(1) and… | −1.2% | −1.1% |
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.